NCT00741845

Prevention of Persistence of Bacterial Vaginosis

Prevention of Persistence of Bacterial Vaginosis: The Effects of High Dose Intravaginal Metronidazole

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 117 (actual)
• Sponsor: Embil Pharmaceutical Co. Ltd · Industry
• Sex: Female
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

This purpose of this study will be to conduct a double-blind, randomized, controlled clinical trial to determine the association between intravaginal high dose metronidazole (750mg), intravaginal high dose metronidazole combined with an antifungal agent(750mg metronidazole + 200mg miconazole) and low dose (37.5mg) intravaginal metronidazole, with the rate of persistent bacterial vaginosis.

Conditions

• Bacterial Vaginosis

Interventions

Type	Name	Description
DRUG	intravaginal metronidazole	high dose intravaginal metronidazole 750mg (with or without miconazole) to be compared to low dose intravaginal metronidazole 37.5mg

Timeline

• Start date: 2008-06-01
• Primary completion: 2009-06-01
• First posted: 2008-08-26
• Last updated: 2012-03-06

Locations

1 site across 1 country: Peru